Lv72
3900 积分 2024-02-08 加入
A Review of Current and Emerging Therapeutic Options for Hemophagocytic Lymphohistiocytosis
20天前
已完结
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
3个月前
已完结
The importance of complex karyotype in prognostication and treatment of chronic lymphocytic leukemia (CLL): a comprehensive review of the literature
6个月前
已完结
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
7个月前
已完结
Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study
8个月前
已完结
Comparison of karyotype scoring guidelines for evaluating karyotype complexity in chronic lymphocytic leukemia
8个月前
已完结
Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)
8个月前
已完结
SOHO State of the Art Updates and Next Questions | Treatment of Richter's Transformation
8个月前
已完结
Diagnosis and Management of Cardiovascular Effects of Bruton's Tyrosine Kinase Inhibitors
8个月前
已完结
Prognostic factors and risk stratification in chronic lymphocytic leukemia
8个月前
已完结
皖公网安备34019202002308
